Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

ATS 3f Aortic Bioprosthesis Model 1000

Study:

ATS 3f Aortic Bioprosthesis Model 1000

Rationale:

n/a

Purpose:

The clinical investigation titled `ATS 3f Aortic Bioprosthesis Model 1000 Study,` is a prospective, non-randomized, multi-center study designed to evaluate the the safety and effectiveness obtained from 800 patient years using a common clinical protocol. Twenty-three (23) sites internationally and in the United States combinded enrolled 405 patients. The objective of the study was to evaluate the safety and effectiveness of the ATS 3f Aortic Bioprosthesis Model equine pericardial prosthesis in a a patient population undergoing isolated aortic valve replacementof his / her native aortic valve, or replacement of a failed prosthesis with or without concominant procedures.

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Heart Valve Diseases Device: ATS 3f Aortic Bioprosthesis Model 1000 N/A

Verified by ATS Medical, Inc. April, 2008

Sponsored by: ATS Medical, Inc.
Information provided by: ATS Medical, Inc.
ClinicalTrials.gov identifier: NCT00657826

Study Type: Interventional

Study Design: Treatment, Safety/Efficacy Study

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site